SENIOR ADVISORY BOARD
H.E. PROF. ARMEN BAIBOURTIAN
Ex Deputy Foreign Minister of Armenia (1997-2000 and 2004-2008)
Ex Ambassador in India, Nepal, Sri Lanka, and Indonesia (2000-2004).
Prof Baibourtian has also been a Senior Adviser to the United Nations Resident Coordinator and UNDP Resident Representative in Armenia (2008-2013). In this capacity, he coordinated the activities of twelve UN agencies on the country scale. Along with the U.S. Deputy Assistant Secretary, Prof Baibourtian co-chaired the U.S.-Armenia Security Dialogue. He also co-chaired bilateral Intergovernmental Commissions on Trade, Economic, Technological, Cultural, and Educational Cooperation with India and China. He was the Deputy Permanent Representative to the UN in New York (1993-1995) dealing with international peace and security issues at the UN Headquarters and then served as the Consul General in Los Angeles (1995-1997). Prof Baibourtian has been a Professor of Practice of Political Science at the University of Massachusetts Amherst and is Consultant to various agencies in international affairs, diplomacy, and international development.
Prof Baibourtian holds two PhDs – in International Studies and Modern World History and is the recipient of several awards, including the Fridtjof Nansen Humanitarian Service Medal.
PROF. RANDEEP GULERIA, MD, DM
All India Institute of Medical Sciences, New Delhi
Prof Guleria is an international expert in Respiratory and Sleep Medicine, and was the Director of the AIIMS, New Delhi from March 2017 to September 2022. Established in 1956 under the Government of India, AIIMS is the apex medical research institute of India and is rated as one of the top medical institutes in the world.
Prof Guleria has been Advisor to and associated with several international organizations including the Center for Disease control, USA, WHO Scientific Advisory Group of Experts (SAGE), Geneva, International Atomic Energy Agency (IAEA), Vienna, European Commission, and has worked at the Royal Brompton Hospital, London.
Prof Guleria was the personal physician to Sri Atal Bihari Vajpayee, former Prime Minister of India since 1998. He has been a member of several committees in the Government of India including the Joint Monitoring Committee to monitor outbreaks of new diseases including Pandemics, bird flu, Ebola etc., to formulate National policy to control antibiotic resistance in India; Program Advisory Committee on Health Science of the Department of Science and Technology; Project Review Committee of the Indian Council of Medical Research; Project Advisory committee of the National Institute of Virology; and Project Advisory Committee on Nutritional Profile of Assam, Manipur and Meghalaya of the ICMR. He has been an advisor to several organizations like UPSC and a member of the Selection Committee for the International Commonwealth fellowship. He is a fellow and member of several National and International bodies including National Academy of Medical Sciences, International Medical Science Academy, Indian Association of Sarcoidosis and Granulomatous Disorders, Association of Physicians of India, National College of Chest Physicians of India, Indian Chest Society and AIDS Society of India.
Prof Guleria sits on the editorial boards of a number of medical journals such as the Indian Journal of Chest Diseases and Lung India. He has done pioneering work on respiratory muscle functions, lung cancer, asthma and COPD and has more than 400 publications in International and National journals and 49 chapters in various National and International books. He has delivered more than 300 lectures in International and National conferences. He has been invited as a faculty to deliver talks in various conferences across the globe and has organized various national and international conferences at AIIMS over the last three decades on HIV, AIDS, Tuberculosis, and other respiratory diseases. He has been an external examiner to various universities including Delhi University, PGI, Chandigarh, VP Chest Institute, KGMC, Lucknow, BHU Varanasi, Amrita Institute of Medical Sciences, Sher-e Kashmir Institute, Srinagar and Universities in Nepal.
During the Pandemic, Prof Guleria co-authored a book Till We Win: India's Fight Against The COVID-19 Pandemic, published by Penguin Random House India that became one of the national bestsellers. This book provides unique blend of information on macro (health policy) as well as micro (how to stay safe in and during pandemic period) issues. The book has sections on viruses, why pandemic happens; India's response to pandemic before and during lockdowns and unlock periods, and key learnings for health sector during these periods. The book has been termed as "An easy to read and an important book driven by science, data and reason' by the editor in chief of India's leading newspaper the Hindustan Times.
Prof Guleria has been working to enhance awareness of various diseases, their prevention and treatment and has given a large number of talks on AIR, Doordarshan, Lok Sabha TV, Zee TV, NDTV, Star News, India TV and Aaj Tak. He has also participated in interactive TV shows for youth regarding problems of smoking and how to quit smoking. He has been actively participating in various environmental causes and has been an expert at various environmental forums concerning air pollution as part of awareness campaign and green school initiative on environment.
Prof Guleria has been a dedicated teacher for undergraduate, postgraduate and DM fellows having supervised more than 40 students in MD (Medicine) and more than 25 students in DM in Pulmonary, Critical Care & Sleep Medicine. Dr. Guleria is the first Indian to get a Doctorate of Medicine (DM) in Pulmonary and Critical Care Medicine. The Department of Pulmonary Medicine & Sleep Disorders he created in 2011 has been ranked as the best department in Pulmonary Medicine in the country multiple times by the NIELSEN survey published in WEEK.
“Covid pandemic has posed substantial technical and ethical challenges highlighting the urgent need of enhanced collaboration amongst Healthcare Professionals in India, US, and across the globe to further strengthen the healthcare systems. Such multilateral knowledge and resource sharing is key to bolster global endeavors in managing communicable as well as and non-communicable diseases.” Prof Randeep Guleria.
Prof Guleria has received innumerable awards including Padma Shri, the fourth highest Indian civilian award in India, and Dr. B C Roy National Award under eminent medical person category by the Medical Council of India. Prof Guleria comes from an family of eminent physicians; he is son of Padma Shri Prof J S Guleria, former Dean of AIIMS, and his younger brother Padma Shri Sandeep Guleria, is a surgeon.
Prof Guleria’s ample global experience and stature renders him an unimaginable vantage point in the field of healthcare. Princeton Foundation will establish a Healthcare Advisory Board with Prof Guleria’s guidance to shape our evolving global strategy bringing together various governmental, non-governmental, and professional organizations envisaged in our “Heal the Humanity”.
DeSalvo K et al. Public Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. NAM Perspect. 2021 Apr 7;2021:10.31478/202104c. doi: 10.31478/202104c. PMID: 34532688; PMCID: PMC8406505.
PROF SHARMILA MAKHIJA, MD, FACOG, MBA
Chairperson, Department of Obstetrics & Gynecology and Women’s Health,
Professor of Gynecologic Oncology,
Chella and Moise Safra Endowed Chair
Albert Einstein College of Medicine and Montefiore Medical Center, NY.
Prof Makhija earned her B.A. in Chemistry from Cornell University and her medical degree from the University of Alabama at Birmingham. She completed her obstetrics and gynecology residency at the University of Louisville Hospital and a fellowship in gynecologic oncology at Memorial Sloan-Kettering Cancer Center in New York. She received her executive MBA from Emory’s Goizueta Business School.
Dr. Makhija has held faculty positions at the University of Pittsburgh and the University of Alabama at Birmingham, where she received the medical education award and the Argus Teaching Award from the medical school. At Emory University, she was division chief of gynecologic oncology, a Georgia Cancer Coalition Distinguished Cancer Scholar, and the Leach Endowed Chair in obstetrics and gynecology. She served as Department Chair of Obstetrics, Gynecology and Women’s Health, was a tenured professor of gynecologic oncology and the Donald E. Baxter Endowed Chair in obstetrics and gynecology at the University of Louisville School of Medicine. While there, she also served as the Chief Medical and Operations Officer for the Center for Women and Infants. At the University of Louisville College of Business executive MBA program, she was an instructor for the course “Economics of Health Sector Management.”
Dr. Makhija has published and lectured nationally and internationally on developmental therapeutics, such as gene therapy and monoclonal antibody therapy for the treatment of ovarian cancer, for which she received NIH funding as a Women’s Reproductive Health Research Scholar. She has been the Primary Investigator or Co-Primary Investigator for 15 translational/clinical grants and protocols for the NIH, NCI and pharmaceutical companies, including the HPV vaccine trials. She has served as a reviewer for the Department of Defense and the NIH Clinical Oncology Study Section.
Dr. Makhija established a NCI cooperative trial site at Tata Hospital in Mumbai, India to bring cervical cancer trials to patients who most needed access to the latest therapies. She has continued her work in India and served as the Women’s Health Co-Chair for the Global Healthcare Summit in New Delhi, India in 2016, sponsored by the AAPI (American Association of Physicians of Indian Origin) with a focus on Maternal and Infant Mortality.
Dr. Makhija is presently on the editorial board for the Journal of Oncology Practice and has served on the editorial boards for the Women’s Oncology Review Journal and International Journal of Gynecological Cancer. She is a reviewer for the journals Gynecologic Oncology, International Journal of Gynecological Cancer, and Clinical Cancer Research.
Dr. Makhija is a graduate of Executive Leadership in Academic Medicine (ELAM), serves on their advisory board and was an elected representative for AAMC CFAS (American Association of Medical Colleges, Council of Faculty and Academic Societies) while at the University of Louisville. She has served as a board of director member of numerous local, state and national organizations including the University of Louisville Medical Center, KMRRRG malpractice, KY Medicaid (Passport). She currently serves on Women’s Voices for Change, the Foundation for Women’s Cancers and the Indo-American Cancer Association. Dr. Makhija has been listed as a “Top Doctor in America” since 2008.
Dr Umakanth Katwa, MD
Pediatric Pulmonologist and Sleep Specialist
Boston Children’s Hospital, Harvard Medical School.
Dr Khatwa completed his pediatric residency at the All India Institute of Medical Sciences, New Delhi and Fellowship in Pediatric Pulmonary and Sleep Medicine at the Harvard. He severed as the Director of the Aerodigestive Center at Boston Children’s Hospital for 7 years and then became the Director of sleep laboratory at the Children’s Hospital. He was recently elected as the President of the Association of American Physicians of Indian Origin – Sleep (AAPIOS), the largest ethnic sleep physician organization in US. His research interests include pediatric sleep disordered breathing and aspiration/reflux related lung disease and has widely published in international journals. Dr. Katwa lectures regularly in national and international conference and is actively involved in training fellows, residents and medical students at Harvard Medical School. He also does educational seminars and teaching regularly in India to increase the awareness of sleep disorders.
Mr Edric Engert, MBA
Abraxeolus Consulting offers a wide array of problem solving leadership and expertise. While Abraxeolus is broad and has worked on such things as HR Visions, Leadership Assessments, Pricing tactics, and sales force/marketing plans, it has its deepest spikes in strategy, the operationalization of strategy, Business Development, and portfolio selection and management. As its MD, Mr Engert assists clients in such areas as strategy, its operationalization, business development/in-licensing, private equity sourcing and advisory roles, portfolio strategy, selection, and management, operational improvement programs, turnarounds, corporate development, and M&A. Abraxeolus has advised a broad range of clients, from multi-billion dollar multinationals to family owned businesses in such industries as Biosimilars, Generics, Branded Pharmaceuticals, API, Healthcare Information Exchanges, medical supply companies, distributors, animal health companies, other consulting firms, and not-for-profit agencies.
He was recently the Senior Vice President and Head of Biosimilars for Teva Pharmaceuticals where he was responsible for the business unit. Other prior positions include Global Head of Portfolio Management & In-licensing at Teva; Global Head of Portfolio Management & In-licensing at Sandoz; VP of Strategic Planning, Portfolio, and API Sourcing at Geneva Pharmaceuticals; and consultant at McKinsey & Company’s health care practice.
Mr Engert holds an MBA from Wharton and a BS in Mathematics from MIT.